ST Jingfeng: The company's stock will be removed from other risk warnings starting on June 12th.

ST Jingfeng announcement, the trading of company's stocks will be suspended for one day on June 11, 2026, and resume trading starting from June 12. Starting from June 12, the company's stocks will cancel the other risk warnings, and the stock abbreviation will be changed from "ST Jingfeng" to "Jingfeng Pharmaceutical." The securities code "000908" remains unchanged, and the daily limit of price increase or decrease is adjusted from 5% to 10%. Previously, due to the negative opinion in the internal control audit report for the year 2023 and uncertainty about the company's continued operation capability, the company's stocks have been subject to other risk warnings since May 6, 2024. Grand Trust Certified Public Accountants issued a standard unqualified audit report on April 27, 2025, confirming that the company has eliminated the risk warning conditions. The company's application to cancel the risk warning has been approved by the Shenzhen Stock Exchange.